Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Aug 29, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, routine-report, foreign-private-issuer
TL;DR
DRL filed a 6-K, just routine paperwork, no big news.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on August 29, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events but serves as a routine submission under SEC regulations.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is complying with its reporting obligations as a foreign private issuer with the SEC, which is standard practice for publicly traded international companies.
Risk Assessment
Risk Level: low — This filing is a routine administrative submission and does not contain any new material information that would impact the company's risk profile.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- SEC (company) — Securities and Exchange Commission
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to submit information that the company has made or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on August 29, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
Does this filing contain specific financial results or material events?
Based on the provided text, this Form 6-K appears to be a routine submission and does not detail specific financial results or material events.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-08-29 13:23:11
Filing Documents
- drr0663_6k.htm (6-K) — 14KB
- drr0663_ex99-1.htm (EX-99.1) — 23KB
- drr0663_ex99-1img01.jpg (GRAPHIC) — 9KB
- drr0663_ex99-1img02.jpg (GRAPHIC) — 3KB
- drr0663_ex99-1img03.jpg (GRAPHIC) — 8KB
- 0001575872-24-000959.txt ( ) — 67KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 29, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3